{"id":30082,"date":"2013-02-15T08:20:45","date_gmt":"2013-02-15T12:50:45","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=30082"},"modified":"2013-02-15T15:42:04","modified_gmt":"2013-02-15T20:12:04","slug":"consensos-sobre-la-prescripcion-y-uso-del-propranolol-para-el-tratamiento-del-hemangioma-infantil-pediatrics-2013","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/30082","title":{"rendered":"Consensos sobre la prescripci\u00f3n y uso del propranolol para el tratamiento del hemangioma infantil. Pediatrics 2013"},"content":{"rendered":"

<\/p>\n

– CONSENSOS SOBRE LA PRESCRIPCI\u00d3N Y USO DEL PROPRANOLOL PARA EL TRATAMIENTO DEL HEMANGIOMA INFANTIL Pediatrics 2013; 131(1): 128-140.<\/i><\/p>\n

Pautas y\u00a0 recomendaciones que reflejen la mejor evidencia existente en el uso del propranolol en el tratamiento del hemangioma infantil.<\/p>\n

– MELANOMA CUT\u00c1NEO: GU\u00cdA PARA SU DIAGN\u00d3STICO, TRATAMIENTO Y SEGUIMIENTO. Annals of Oncology 2012; 23 (Supplement 7): vii86-vii91.<\/i><\/p>\n

Gu\u00eda cl\u00ednica de European Society for Medical Oncology (ESMO) para el\u00a0 mejor manejo cl\u00ednico del Melanoma maligno acorde a las evidencias actualmente disponibles.<\/p>\n

– Cordialmente enviado por Dr. Juan Chassaigne<\/i><\/p>\n

Pediatrics <\/i>2013;131;397;<\/p>\n

Recommended Childhood and Adolescent Immunization Schedule<\/b>—United<\/b><\/p>\n

http:\/\/pediatrics.aappublications.org\/content\/131\/2\/397.full.html<\/a><\/b><\/p>\n

–\u00a0 <\/b>Cordialmente enviado por Dr. Juan Chassaigne<\/i> <\/b><\/p>\n

Annals of Internal Medicine <\/b>Clinical Guideline
www.annals.org <\/b>5 February 2013 Annals of Internal Medicine Volume 158 \u2022 Number 3 191
<\/b>Recommended Adult Immunization Schedule: United States, 2013*
<\/b>Advisory Committee on Immunization Practices\u2020<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":16,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,1],"tags":[],"class_list":["post-30082","post","type-post","status-publish","format-standard","","category-comunicaciones-importantes","category-generales"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/30082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=30082"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/30082\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=30082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=30082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=30082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}